Bausch & Lomb Incorporated

🇺🇸United States
Ownership
-
Established
1992-10-08
Employees
-
Market Cap
-
Website

A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte

First Posted Date
2005-09-20
Last Posted Date
2013-03-15
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
132
Registration Number
NCT00198523
Locations
🇺🇸

Cornea Consultants/Laser Eye Consultants of Boston, Boston, Massachusetts, United States

🇺🇸

Donald E. Beahm, MD, Great Bend, Kansas, United States

🇺🇸

Great Lakes Eye Care, St. Joseph, Michigan, United States

and more 3 locations

Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics

Phase 4
Completed
Conditions
First Posted Date
2005-09-20
Last Posted Date
2013-03-19
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
40
Registration Number
NCT00198549
Locations
🇺🇸

Cincinnati Eye Institute, Cincinnati, Ohio, United States

Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2005-09-20
Last Posted Date
2013-03-18
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
65
Registration Number
NCT00198458
Locations
🇺🇸

Solano Clinical Research (A Division of Dow Pharmaceutical Sciences), Davis, California, United States

Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

Phase 3
Completed
Conditions
Interventions
First Posted Date
2005-09-20
Last Posted Date
2013-03-15
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
750
Registration Number
NCT00198510
Locations
🇺🇸

Illinois Retina Associates SC, Chicago, Illinois, United States

🇺🇸

Retina Center at Pali Momi, Aiea, Hawaii, United States

🇺🇸

King Y. Lee, MD, Shawnee Mission, Kansas, United States

and more 70 locations

Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment

Phase 2
Completed
Conditions
Interventions
First Posted Date
2005-09-20
Last Posted Date
2013-03-15
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
10
Registration Number
NCT00198471
Locations
🇺🇸

Edgar L. Thomas, MD, Beverly Hills, California, United States

🇺🇸

Valley Retina Institute, PA, McAllen, Texas, United States

🇺🇸

Ronni Lieberman, MD, New York, New York, United States

and more 1 locations

Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

First Posted Date
2005-09-20
Last Posted Date
2013-03-15
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
510
Registration Number
NCT00198497
Locations
🇿🇦

Nasionale Hospital, Bloemfontein, South Africa

🇵🇱

Klinika Chorob Oczu, Bydgoszcz, Poland

🇵🇱

Ophtalmology Clinic, Gdansk, Poland

and more 55 locations

Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome

First Posted Date
2005-09-20
Last Posted Date
2013-03-14
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
159
Registration Number
NCT00198536
Locations
🇺🇸

Eyesight Ophthalmic Services, PA, Dover, New Hampshire, United States

🇺🇸

Central Maine Eye Care, Lewiston, Maine, United States

🇺🇸

Andover Eye Associates, Andover, Massachusetts, United States

Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2005-09-20
Last Posted Date
2013-03-14
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
65
Registration Number
NCT00198419
Locations
🇺🇸

Solano Clinical Research (A Division of Dow Pharmaceutical Sciences), Davis, California, United States

Evaluation of Vitrase as a Spreading Agent

Phase 3
Completed
Conditions
Interventions
First Posted Date
2005-09-20
Last Posted Date
2013-03-14
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
108
Registration Number
NCT00198484
Locations
🇺🇸

Donald E Beahm, MD, Great Bend, Kansas, United States

🇺🇸

Ophthalmic Consultants of Long Island, Rockville Centre, New York, United States

🇺🇸

Cornea Consultants, Boston, Massachusetts, United States

and more 15 locations

Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery

First Posted Date
2005-09-20
Last Posted Date
2013-03-14
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
527
Registration Number
NCT00198445
Locations
🇺🇸

Eye Care of San Diego, San Diego, California, United States

🇺🇸

Cornea Consultants, Boston, Massachusetts, United States

🇺🇸

Ophthalmic Consultants of Long Island, Rockville Centre, New York, United States

and more 36 locations
© Copyright 2024. All Rights Reserved by MedPath